Skip to main content
. 2014 May 27;2(2):397–421. doi: 10.3390/vaccines2020397

Figure 5.

Figure 5

The long-term outcome using the sample values in Table 1 for the case when both mutants have 100-fold resistance (pM1 = 0.01pW, pM2 = 0.01pW) as the antibody magnification factor m varies. (A) m = 1; (B) m = 10; (C) m = 50; (D) the same as (C), except with no initial mutants.